www.fdanews.com/articles/97029-mylan-announces-final-fda-approval-for-verapamil-hydrochloride-extended-release-capsules
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules
August 10, 2007
Mylan Laboratories Inc. announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Verapamil Hydrochloride (HCl) Extended-release (ER) Capsules (PM), 100 mg, 200 mg and 300 mg.
PR Newswire